Previous Page  5 / 10 Next Page
Information
Show Menu
Previous Page 5 / 10 Next Page
Page Background

Page 19

Notes:

Volume 3

Journal of Reproductive Biology and Endocrinology

WCGO2019

May 13-14 , 2019

Gynecology and Obstetrics

May 13-14 , 2019 Tokyo, Japan

2

nd

World Congress on

Incidental intravascular leiyomyomatosis: A case report and review of the literature

Samara Tahreen Sabur

Northern Beaches Hospital, Australia

Intravascular Leiyomyomatosis (IVL) is a rare smooth muscle cell tumour that is histologically benign with

metastatic behaviour. The tumour arises from the uterus and grows within the venous system, extending to

the inferior vena cava, right-sided cardiac chambers and pulmonary vessels. IVL can be fatal, resulting in

thromboembolic events, congestive heart failure and intra-pulmonary leiyomyomatosis. There is also a risk of

recurrence if the tumour is not completely resected.

Presentation usually occurs after the disease has advanced with symptoms of haemodynamic instability,

dyspnoea, palpitations, chest or abdominal pain.2 Typically, diagnosis is based on macroscopic description of

worm-like tumour projections in the veins and/or microscopic evidence of intraluminal leiyomyomas.

We report a case of a 44-year-old woman who underwent a total abdominal hysterectomy and bilateral

salpingectomy for simple hyperplasia, diagnosed from uterine curettage performed for menorrhagia.

Intraoperatively, increased vascularity and aberrant vessels were noted on the serosal surface. The macroscopic

pathology examination was normal, however, the histopathology demonstrated smooth muscle tumours in 2

vessels, consistent with IVL.

The patient underwent computed tomography imaging of the chest and abdomen to rule out metastases and is

scheduled for yearly follow-up due to the risk of recurrence. This case highlights a rare but important diagnosis

that gynecologists should be suspicious of when abnormal vascularity is seen on the uterus, especially due to

the high risk of morbidity and recurrence with IVL. We review the literature and discuss management options

for optimal outcomes of this disease.

Biography

Samara Sabur is a junior medical doctor, training in obstetrics and gynecology at the Northern Beaches Hospital in Sydney, Australia.

She is currently completing a Master of Public Health through the University of Sydney and is an associate lecturer at the School

of Medicine in University of Western Sydney. She has previously presented research at the European Congress of Obstetrics and

Gynecology as well as the Australasian Gynecological and Endoscopy Society annual scientific meeting.

samara.sabur@gmail.com

J Reprod Biol Endocrinol, Volume 3